296 related articles for article (PubMed ID: 29751748)
1. Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis.
Kärkkäinen M; Nurmi H; Kettunen HP; Selander T; Purokivi M; Kaarteenaho R
BMC Pulm Med; 2018 May; 18(1):69. PubMed ID: 29751748
[TBL] [Abstract][Full Text] [Related]
2. Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.
Salonen J; Purokivi M; Bloigu R; Kaarteenaho R
BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32265195
[TBL] [Abstract][Full Text] [Related]
3. Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis.
Kärkkäinen M; Kettunen HP; Nurmi H; Selander T; Purokivi M; Kaarteenaho R
Respir Res; 2017 Aug; 18(1):160. PubMed ID: 28830514
[TBL] [Abstract][Full Text] [Related]
4. Mortality Associated with Idiopathic Pulmonary Fibrosis in Northeastern Italy, 2008-2020: A Multiple Cause of Death Analysis.
Marcon A; Schievano E; Fedeli U
Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299699
[TBL] [Abstract][Full Text] [Related]
5. Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
Oda K; Yatera K; Fujino Y; Kido T; Hanaka T; Sennari K; Fushimi K; Matsuda S; Mukae H
Respir Investig; 2018 Jan; 56(1):64-71. PubMed ID: 29325684
[TBL] [Abstract][Full Text] [Related]
6. [Idiopathic pulmonary fibrosis prognostic factors - analysis of the Czech registry].
Doubková M; Uher M; Bartoš V; Šterclová M; Lacina L; Lošťáková V; Binková I; Plačková M; Žurková M; Bittenglová R; Pšikalová J; Šišková L; Lisá P; Petřík F; Polák J; Řihák V; Skřičková J; Vašáková M
Cas Lek Cesk; 2016; 155(4):22-8. PubMed ID: 27481198
[TBL] [Abstract][Full Text] [Related]
7. Gender differences at presentation of idiopathic pulmonary fibrosis in Sweden.
Kalafatis D; Gao J; Pesonen I; Carlson L; Sköld CM; Ferrara G
BMC Pulm Med; 2019 Nov; 19(1):222. PubMed ID: 31771560
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic pulmonary fibrosis: Clinical behavior and aging associated comorbidities.
Buendía-Roldán I; Mejía M; Navarro C; Selman M
Respir Med; 2017 Aug; 129():46-52. PubMed ID: 28732835
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and factors associated with mortality in idiopathic pulmonary fibrosis: An experience from a tertiary care center in Pakistan.
Zubairi ABS; Ahmad H; Hassan M; Sarwar S; Abbas A; Shahzad T; Irfan M
Clin Respir J; 2018 Mar; 12(3):1191-1196. PubMed ID: 28508572
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF).
Krauss E; Gehrken G; Drakopanagiotakis F; Tello S; Dartsch RC; Maurer O; Windhorst A; von der Beck D; Griese M; Seeger W; Guenther A
BMC Pulm Med; 2019 Jul; 19(1):130. PubMed ID: 31319833
[TBL] [Abstract][Full Text] [Related]
11. The predictors of mortality in IPF - Does emphysema change the prognosis?
Tokgoz Akyıl F; Sevim T; Akman C; Aksoy E; Ağca M; Aktas O; Akyıl M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):267-274. PubMed ID: 27758993
[TBL] [Abstract][Full Text] [Related]
12. Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis.
Kaunisto J; Kelloniemi K; Sutinen E; Hodgson U; Piilonen A; Kaarteenaho R; Mäkitaro R; Purokivi M; Lappi-Blanco E; Saarelainen S; Kankaanranta H; Mursu A; Kanervisto M; Salomaa ER; Myllärniemi M
BMC Pulm Med; 2015 Aug; 15():92. PubMed ID: 26285574
[TBL] [Abstract][Full Text] [Related]
13. The clinical impact of major comorbidities on idiopathic pulmonary fibrosis.
Suzuki A; Kondoh Y
Respir Investig; 2017 Mar; 55(2):94-103. PubMed ID: 28274539
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
[TBL] [Abstract][Full Text] [Related]
15. Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis.
Daniels CE; Yi ES; Ryu JH
Eur Respir J; 2008 Jul; 32(1):170-4. PubMed ID: 18256070
[TBL] [Abstract][Full Text] [Related]
16. Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung.
Antoniou KM; Walsh SL; Hansell DM; Rubens MR; Marten K; Tennant R; Hansel T; Desai SR; Siafakas NM; du Bois RM; Wells AU
Respirology; 2013 Nov; 18(8):1191-6. PubMed ID: 23819865
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic pulmonary fibrosis with emphysema: evidence of synergy among emphysema and idiopathic pulmonary fibrosis in smokers.
Mitchell PD; Das JP; Murphy DJ; Keane MP; Donnelly SC; Dodd JD; Butler MW
Respir Care; 2015 Feb; 60(2):259-68. PubMed ID: 25389350
[TBL] [Abstract][Full Text] [Related]
18. Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosis.
Aggarwal R; McBurney C; Schneider F; Yousem SA; Gibson KF; Lindell K; Fuhrman CR; Oddis CV
Rheumatology (Oxford); 2017 Mar; 56(3):384-389. PubMed ID: 28082622
[TBL] [Abstract][Full Text] [Related]
19. In-Hospital Mortality in Patients with Idiopathic Pulmonary Fibrosis: A US Cohort Study.
Durheim MT; Judy J; Bender S; Baumer D; Lucas J; Robinson SB; Mohamedaly O; Shah BR; Leonard T; Conoscenti CS; Palmer SM
Lung; 2019 Dec; 197(6):699-707. PubMed ID: 31541276
[TBL] [Abstract][Full Text] [Related]
20. Characterizing idiopathic pulmonary fibrosis patients using US Medicare-advantage health plan claims data.
Mortimer K; Hartmann N; Chan C; Norman H; Wallace L; Enger C
BMC Pulm Med; 2019 Jan; 19(1):11. PubMed ID: 30630460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
